Green Planet Bio Engineering Co. Ltd. (GPLB)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (13)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06813495 | Eastern Principles Acceptance and Commitment Therapy For Injury Prevention Among Nurses and Nursing Aides | OTHER | Recruiting | 255 |
| NCT04694235 | Egg Intervention During Pregnancy in Indonesia | OTHER | Active Not Recruiting | 702 |
| NCT06998680 | 6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair | OTHER | Recruiting | 152 |
| NCT04763291 | Cardiovascular and InflammAging Study | OTHER | Active Not Recruiting | 80 |
| NCT05058040 | A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) | PHASE4 | Active Not Recruiting | 2,500 |
| NCT05181475 | Long-term Efficacy and Safety Study of GV-971 | PHASE4 | Active Not Recruiting | 800 |
| NCT05288452 | Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM) | OTHER | Active Not Recruiting | 304 |
| NCT05908695 | An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease | PHASE4 | Recruiting | 1,312 |
| NCT06423547 | Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients | OTHER | Recruiting | 10,000 |
| NCT05255653 | Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features | PHASE3 | Recruiting | 1,615 |
| NCT06493799 | In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Pl... | PHASE3 | Recruiting | 226 |
| NCT05422508 | Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children... | PHASE2 | Recruiting | 230 |
| NCT07510607 | Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis | PHASE2 | Recruiting | 40 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.